Green Thumb Industries (GTBIF) EBITDA (2019 - 2026)
Green Thumb Industries (GTBIF) posted EBITDA of $40.7 million for Q1 2026, up 113.89% on a QoQ basis from $19.0 million in Q4 2025, and down 4.11% year-over-year from $42.5 million in Q1 2025.
Green Thumb Industries (GTBIF) EBITDA (2019 - 2026) Analysis & Trends
Green Thumb Industries' EBITDA history runs 8 years deep, the most recent figure standing at $40.7 million for Q1 2026.
- Quarterly EBITDA fell 4.11% year-over-year to $40.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136.0 million (down 30.72% YoY) and the FY2025 annual result came in at $137.7 million, down 38.64% from the prior year.
- EBITDA was $40.7 million for Q1 2026 at Green Thumb Industries, up from $19.0 million in the prior quarter.
- Across five years, EBITDA topped out at $70.7 million in Q1 2024 and bottomed at -$44.5 million in Q4 2022.
- A 5-year average of $41.7 million and a median of $44.2 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA plunged 181.85% — and 2023, when it surged 213.09%.
- Green Thumb Industries' EBITDA stood at -$44.5 million in 2022, then jumped by 213.09% to $50.3 million in 2023, then climbed by 13.45% to $57.1 million in 2024, then slumped by 66.65% to $19.0 million in 2025, then surged by 113.89% to $40.7 million in 2026.
- Business Quant data shows GTBIF's EBITDA at $40.7 million in Q1 2026, $19.0 million in Q4 2025, and $36.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 40.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.73 Mn |
| Dec 31, 2025 | 19.04 Mn |
| Sep 30, 2025 | 36.74 Mn |
| Jun 30, 2025 | 39.43 Mn |
| Mar 31, 2025 | 42.48 Mn |
| Dec 31, 2024 | 57.11 Mn |
| Sep 30, 2024 | 42.62 Mn |
| Jun 30, 2024 | 54.02 Mn |
| Mar 31, 2024 | 70.67 Mn |
| Dec 31, 2023 | 50.34 Mn |
| Sep 30, 2023 | 49.03 Mn |
| Jun 30, 2023 | 41.06 Mn |
| Mar 31, 2023 | 44.20 Mn |
| Dec 31, 2022 | -44.51 Mn |
| Sep 30, 2022 | 48.76 Mn |
| Jun 30, 2022 | 62.26 Mn |
| Mar 31, 2022 | 54.55 Mn |
| Dec 31, 2021 | 54.38 Mn |
| Sep 30, 2021 | 58.07 Mn |
| Jun 30, 2021 | 50.86 Mn |